Clinical Trial Site — Detroit, Michigan

Clinical Trial Site is a clinical research site located in Detroit, Michigan, United States 48201.

Crixeo Health Trust Score: 78/100 (FAIR). This profile has not yet been claimed by the site owner.

Clinical Trial Site has participated in 14 clinical trials with 7 currently active.

Therapeutic areas: Prostate Cancer Metastatic, TTR-mediated Amyloidosis, Amyloidosis, Hereditary.

Sponsors: Novartis Pharmaceuticals, Alnylam Pharmaceuticals, Olema Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 78/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Clinical Trial Site?

Clinical Trial Site has a Crixeo Trust Score of 78/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Clinical Trial Site conducted?

Clinical Trial Site has 14 clinical trials on record, with 7 currently active. Their work covers Prostate Cancer Metastatic, TTR-mediated Amyloidosis, Amyloidosis, Hereditary.

Is Clinical Trial Site accredited by Crixeo Health?

Yes — Clinical Trial Site holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Clinical Trial Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.